Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 139,036	$ 143,940
Restricted cash	449	449
Prepaid expenses and other current assets	2,645	3,479
Assets held for sale		2,000
Total current assets	142,130	149,868
Restricted cash	2,151	2,151
Property, plant and equipment, net	7,485	10,826
Operating lease right-of-use assets	8,381	9,582
Other non-current assets	217	304
Total assets	160,364	172,731
Current liabilities
Accounts payable	3,592	6,366
Accrued expenses and other current liabilities	12,862	12,284
Deferred revenue	9,773	18,106
Total current liabilities	26,227	36,756
Term loan, net	43,942	40,508
Operating lease liability, net of current portion	17,361	18,953
Other non-current liabilities	1,309	1,577
Total liabilities	88,839	97,794
Commitments and contingencies - Note 13
Stockholders' equity
Preferred stock, $0.00001 par value per share; 10,000,000 shares authorized and no shares issued and outstanding as of December 31, 2024 and December 31, 2023
Common stock, $0.00001 par value per share; 400,000,000 shares authorized and 204,943,306 and 186,960,193 issued and outstanding as of December 31, 2024 and December 31 2023, respectively	2	2
Additional paid-in capital	677,859	587,942
Accumulated other comprehensive loss	(4,031)
Accumulated deficit	(602,305)	(513,007)
Total stockholders’ equity	71,525	74,937
Total liabilities and stockholders' equity	$ 160,364	$ 172,731